SCHEMBL27459079

SCHEMBL27459079

COC(=O)c1cc(Br)cc(-c2cccs2)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.51
NPC1 O15118 2/20 0.51
TP53 P04637 1/20 0.51
RAB9A P51151 1/20 0.51
ATM Q13315 1/20 0.51
KDM4E B2RXH2 2/20 0.47
THRB P10828 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
NR4A2 P43354 1/20 0.46
KMT2A Q03164 5/20 0.46
L3MBTL1 Q9Y468 4/20 0.46
MEN1 O00255 4/20 0.46
NOTUM Q6P988 1/20 0.46
BLM P54132 1/20 0.44
CTDSP1 Q9GZU7 1/20 0.44
ABL1 P00519 1/20 0.43
BCR P11274 1/20 0.43
ACLY P53396 1/20 0.43
ERN1 O75460 1/20 0.42
ALDH1A1 P00352 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9637810 0.82 PTPN1 (0.48) MAPTKDM4EKMT2AMEN1ABL1
SCHEMBL6802813 0.81 HTR1A (0.54) MAPTNPC1TP53RAB9AATM
SCHEMBL9637378 0.81 CHEK1 (0.48) MAPTKDM4EABL1BCRERN1
SCHEMBL3193250 0.79 MAPT (0.66) MAPTNPC1TP53RAB9AATM
SCHEMBL7336149 0.79 MAPT (0.66) MAPTNPC1TP53RAB9AATM
SCHEMBL31437962 0.77 CYP2A6 (0.52) MAPTNPC1TP53RAB9AATM
SCHEMBL1334676 0.76 KCNH2 (0.48) MAPTNPC1RAB9AKDM4ETDP1
SCHEMBL9193569 0.76 KCNH2 (0.48) MAPTNPC1RAB9AKDM4ETDP1
SCHEMBL27459078 0.75 LPL (0.55) MAPTNPC1TP53RAB9AATM
Methyl 3,5-Dibromobenzoate SCHEMBL2408987 0.74 NOTUM (0.67) MAPTATMKDM4ETDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240208961-A1 EIF4E INHIBITORS AND USES THEREOF PIC Therapeutics, Inc. 2024-06-27 US disclosed
US-20240208961-A1 EIF4E INHIBITORS AND USES THEREOF PIC Therapeutics, Inc. 2024-06-27 US disclosed
US-20240208961-A1 EIF4E INHIBITORS AND USES THEREOF PIC Therapeutics, Inc. 2024-06-27 US disclosed
WO-2024112894-A1 EIF4E INHIBITORS AND USES THEREOF PIC Therapeutics, Inc. (US) 2024-05-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240208961-A1 EIF4E INHIBITORS AND USES THEREOF EIF4E, EIF4EBP1, EIF4A1 MAPT 2231/4885NPC1 2317/4885TP53 1553/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.